ArticleJournal of clinical medicine2026
Sacubitril/Valsartan Improves Functional Capacity and Reverses LV Remodeling in Obese Patients with Hypertrophic HFpEF: A Randomized Open-Label Study.
Artem Ovchinnikov, Alexandra Potekhina, Anastasiya Shchendrygina, Olga Svirida, Maria Sobolevskaya, Zoya Blankova, Maria Glezer, Fail Ageev
Abstract read
In one paragraphArticle in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Artem OvchinnikovLaboratory of Myocardial Fibrosis and Heart Failure with Preserved Ejection Fraction, National Medical Research Center of Cardiology Named After Academician E.I. Chazov, Academician Chazov St., 15a, 121552 Moscow, Russia.ORCID 0000-0003-3285-6148 Alexandra PotekhinaLaboratory of Myocardial Fibrosis and Heart Failure with Preserved Ejection Fraction, National Medical Research Center of Cardiology Named After Academician E.I. Chazov, Academician Chazov St., 15a, 121552 Moscow, Russia.ORCID 0000-0001-9290-9884 Anastasiya ShchendryginaDepartment of Inpatient Medicine No. 2, M. Sechenov First Moscow State Medical University, Trubetskaya St., 8-2, 119991 Moscow, Russia.
Olga SviridaLaboratory of Myocardial Fibrosis and Heart Failure with Preserved Ejection Fraction, National Medical Research Center of Cardiology Named After Academician E.I. Chazov, Academician Chazov St., 15a, 121552 Moscow, Russia.ORCID 0000-0003-1317-036X Maria SobolevskayaLaboratory of Myocardial Fibrosis and Heart Failure with Preserved Ejection Fraction, National Medical Research Center of Cardiology Named After Academician E.I. Chazov, Academician Chazov St., 15a, 121552 Moscow, Russia.ORCID 0009-0006-7641-5191 Zoya BlankovaLaboratory of Myocardial Fibrosis and Heart Failure with Preserved Ejection Fraction, National Medical Research Center of Cardiology Named After Academician E.I. Chazov, Academician Chazov St., 15a, 121552 Moscow, Russia.
Maria GlezerDepartment of Cardiology, The Vladimirsky Moscow Regional Research Clinical Institute, Shchepkina Street, 61/2, 129110 Moscow, Russia.
Fail AgeevOut-Patient Department, National Medical Research Center of Cardiology Named After Academician E.I. Chazov, Academician Chazov St., 15a, 121552 Moscow, Russia.
Funding
Ministry of Health of the Russian Federation 221021900128-6
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
diastolic dysfunctionheart failure with preserved ejection fractionleft ventricular hypertrophynatriuretic peptidesobesitysacubitril/valsartan
Identifiers
PMID42279146
PMCPMC13257466
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390